0001209191-17-018270.txt : 20170306 0001209191-17-018270.hdr.sgml : 20170306 20170306160926 ACCESSION NUMBER: 0001209191-17-018270 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170302 FILED AS OF DATE: 20170306 DATE AS OF CHANGE: 20170306 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 311 ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 311 ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Murphy Raymond G. CENTRAL INDEX KEY: 0001461806 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 17667951 MAIL ADDRESS: STREET 1: 14604 CARROLTON ROAD CITY: ROCKVILLE STATE: MD ZIP: 20853 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-02 0 0000917520 INTEGRA LIFESCIENCES HOLDINGS CORP IART 0001461806 Murphy Raymond G. 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 1 0 0 0 Common Stock 2017-03-02 4 M 0 5238 10.74 A 66132 D Common Stock 2017-03-02 4 S 0 5238 43.0065 D 60894 D Non-Qualified Stock Option (right to buy) 10.74 2017-03-02 4 M 0 5238 0.00 D 2017-05-20 Common Stock 5238 0 D On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4. The price shown above represents the weighted average price of the shares sold. The range of sale prices was $42.84 to $43.09. 25% of the stock options vested every quarter from the grant date of 5/20/2009. This employee's stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. /s/ Richard D. Gorelick; Attorney-in-Fact 2017-03-06 EX-24.4_709619 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby authorizes Amritpal Deol, Lisa Evoli, Richard D. Gorelick, Mythili Seshan, David Sirolly and Barbara Vietor to execute for and on behalf of the undersigned Forms 3, 4 and 5, and any amendments thereto, and cause such form(s) to be filed with the United States Securities and Exchange Commission pursuant to Section 16(a) of the Securities Act of 1934, relating to the undersigned's beneficial ownership of securities in Integra LifeSciences Holdings Corporation (the "Company"). The undersigned also authorizes the above persons to execute for and on behalf of the undersigned any Form ID or similar document required to obtain or renew Securities and Exchange Commission electronic filings codes and passwords and cause such form(s) to be submitted to and/or filed with the Securities and Exchange Commission. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of, and transactions in, securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 6th day of March, 2017. /s/ Raymond Murphy Raymond Murphy